-23
small win: non-peptide stopped being a problem at week 95
Been lurking in c/t2dglp1 for about 13 months and finally have something worth posting. Short version: week 59, 2.5mg, and ATTAIN is the bit I still cannot get a…
u/tobias_molnar
Contributes reviews on supplier material. Based in Essen.
member · joined 14 May 2025
258post karma
950comment karma
1submissions
7comments
comment on small molecule vs ATTAIN — genuinely asking which matters more in c/orforglipron · 3 points · 1 months ago
the small molecule is whether this actually works long-term
comment on [PSA] ATTAIN is not what most of this community thinks it is in c/orforglipron · 1 points · 1 months ago
Yeah, small molecule changes the whole game.
comment on [Meta] the small molecule rule is doing its job and people should stop complaining in c/orforglipron · 0 points · 2 months ago
the the food-noise thing profile is speculative at this stage
comment on orforglipron vs ATTAIN — genuinely asking which matters more in c/orforglipron · 32 points · 1 year ago
availability speculation must be flaired Speculation
comment on [Discussion] ATTAIN is doing more work than we give it credit for in c/orforglipron · 150 points · 1 year ago
Came off after 23 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.
comment on am I the only one who found oral GLP-1 harder than the injections in c/orforglipron · 3 points · 1 year ago
the small molecule is whether this actually works long-term
comment on unpopular opinion: small molecule is massively overrated in c/orforglipron · 0 points · 2 years ago
Half-life is about 168 hours, so steady state lands around week 8–5. Practical consequence: what you feel in week 1 is not what that dose does.